• To be continued. . .

  • December 2023

    Established the subsidiary in Indonesia

  • December 2022

    Established the subsidiary in the USA.

  • 27 October 2022

    BioPerfectus cooperated with the World Health Organization to facilitate the development of molecular diagnostics in Africa, supplying nucleic acid extraction systems for the effort.

  • 26 September 2022

    BioPerfectus, as the first Chinese company, supplied Ebola Virus Real-Time PCR Kits during the African Ebola outbreak, in collaboration with the Africa CDC and the Uganda Ministry of Health.

  • 25 June 2022

    BioPerfectus has received approvals from 216 professional regulators, including the NMPA, U.S. FDA, CE Mark, ANVISA, SAPHRA, MHRA, WHO-EUL, and others. The company's products are now distributed in more than 100 countries worldwide.

  • 20 June 2022

    Established the subsidiary in the UK.

  • 23 May 2022

    The BioPerfectus Monkeypox Virus Real Time PCR Kit was CE certified and launched quickly within 7 days after the WHO confirmed monkeypox cases.

  • 12 April 2022

    BioPerfectus Nucleic Acid Extractor SSNP-2000B won iF Design Award.

  • 21 February 2022

    Collaboration with FIND to enhance COVID-19 self-testing in LMICs.

  • 20 December 2021

    Expanded presence to over 80 countries.

1 2 3